AmbioPharm (revision 1)
Old revision·09:00, 2 Oct 2025·RetinopathyRex
This is an old revision of this page, as it stood at 09:00, 2 Oct 2025, saved by RetinopathyRex with the summary start organisation article — registry facts and product scope only. It may differ substantially from the current revision, and any error it contains may since have been corrected.
| AmbioPharm, Inc. | |
|---|---|
| Legal name | AmbioPharm, Inc. |
| Trading name | AMB |
| Other designations | AmbioPharm, AmbioPharm Beijing, 安必奥医药 |
| Organisation infobox · conventions | |
AmbioPharm, Inc. (trading as AMB; ambiopharm.net) is a peptide active-ingredient manufacturer and contract development organisation trading as AmbioPharm from Beijing, China, incorporated in 2003 and supplying research peptides and raw materials with batch documentation.[1][2]
The organisation is one of twenty-eight covered on PeptidePedia under Project:Vendor notability. Like the others, it distributes material labelled for research use only, which is not approved for human use in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.[3]
References
- ^ National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration record, retrieved 2026. Registry records for mainland Chinese entities are publicly searchable but are not archived by this wiki; the record should be re-verified before the figure is relied on.
- ^ Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per Project:Verifiability.
- ^ Research-use-only labelling practice; see Research use only for the legal and commercial function of the phrase.
Categories: